NIHR CRDC-PC: South Gloucestershire

Our extensive industry research experience has enabled consistently high performance in commercial clinical trial recruitment, with a strong track record of delivering studies to time and target.

We have met or exceeded recruitment targets in 94% of all industry trials ever completed, including 28 industry studies completed since 2020. Since 2018, we have exceeded recruitment targets in 26 industry studies, often significantly, recruiting more than 175 additional patients above target across this period. We have been the highest UK recruiting site in three studies in the last 12 months.

Our site has also demonstrated strong early activation capability, acting as the first UK site to recruit in 8 studies over the past four years, and the first site in Europe for a further 2 studies. This reflects both speed of start-up and sponsor confidence in delivery performance.

Our ability to deliver consistently is supported by a stable, experienced research team, enabling strong continuity of care and contributing to high retention rates.

We are experienced across a broad range of clinical research areas typically encountered in general practice, and regularly deliver Phase II, III and IV CTIMP trials. This includes both interventional and real-world evidence studies across multiple therapeutic areas.